NO20010833L - Orale mukoadhesive sammensetninger inneholdende gastrointestinale aktive bestanddeler - Google Patents

Orale mukoadhesive sammensetninger inneholdende gastrointestinale aktive bestanddeler

Info

Publication number
NO20010833L
NO20010833L NO20010833A NO20010833A NO20010833L NO 20010833 L NO20010833 L NO 20010833L NO 20010833 A NO20010833 A NO 20010833A NO 20010833 A NO20010833 A NO 20010833A NO 20010833 L NO20010833 L NO 20010833L
Authority
NO
Norway
Prior art keywords
composition
component
mucoadhesive compositions
active ingredients
compositions containing
Prior art date
Application number
NO20010833A
Other languages
English (en)
Norwegian (no)
Other versions
NO20010833D0 (no
Inventor
Douglas Joseph Dobrozsi
Todd Ehren Vienneau
Christopher Robert Mayer
Kishorkumar Jivanlal Desai
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of NO20010833D0 publication Critical patent/NO20010833D0/no
Publication of NO20010833L publication Critical patent/NO20010833L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO20010833A 1998-08-24 2001-02-19 Orale mukoadhesive sammensetninger inneholdende gastrointestinale aktive bestanddeler NO20010833L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US9757698P 1998-08-24 1998-08-24
PCT/US1999/019140 WO2000010527A1 (en) 1998-08-24 1999-08-24 Oral mucoadhesive compositions containing gastrointestinal actives

Publications (2)

Publication Number Publication Date
NO20010833D0 NO20010833D0 (no) 2001-02-19
NO20010833L true NO20010833L (no) 2001-02-19

Family

ID=22264116

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20010833A NO20010833L (no) 1998-08-24 2001-02-19 Orale mukoadhesive sammensetninger inneholdende gastrointestinale aktive bestanddeler

Country Status (15)

Country Link
US (1) US20010016577A1 (ko)
EP (1) EP1115378A1 (ko)
JP (1) JP2002523352A (ko)
KR (1) KR20010072463A (ko)
CN (1) CN1313755A (ko)
AU (1) AU5685299A (ko)
BR (1) BR9913227A (ko)
CA (1) CA2338688A1 (ko)
CO (1) CO5140071A1 (ko)
HU (1) HUP0103216A2 (ko)
ID (1) ID27728A (ko)
NO (1) NO20010833L (ko)
PE (1) PE20000860A1 (ko)
TR (1) TR200100629T2 (ko)
WO (1) WO2000010527A1 (ko)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2801791B1 (fr) * 1999-12-03 2003-05-30 Elpronat Composition pour animaux contenant du salicylate de methyle
CA2467763C (en) * 2001-12-21 2011-09-13 Alcon, Inc. Use of synthetic inorganic nanoparticles as carriers for ophthalmic and otic drugs
EP1815868A3 (en) * 2002-09-26 2007-08-15 Astellas Pharma Inc. Drug absorptivity improving agent
US8679545B2 (en) 2005-11-12 2014-03-25 The Regents Of The University Of California Topical corticosteroids for the treatment of inflammatory diseases of the gastrointestinal tract
US8324192B2 (en) 2005-11-12 2012-12-04 The Regents Of The University Of California Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
US8497258B2 (en) 2005-11-12 2013-07-30 The Regents Of The University Of California Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
MX349677B (es) 2007-11-13 2017-08-08 Meritage Pharma Inc Composiciones corticosteroides.
US20090131386A1 (en) * 2007-11-13 2009-05-21 Meritage Pharma, Inc. Compositions for the treatment of inflammation of the gastrointestinal tract
US20100216754A1 (en) * 2007-11-13 2010-08-26 Meritage Pharma, Inc. Compositions for the treatment of inflammation of the gastrointestinal tract
DE102008019339A1 (de) * 2008-04-16 2009-10-22 Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh Zusammensetzung für die medizinische Anwendung, insbesondere Antazidum
WO2011017489A1 (en) * 2009-08-05 2011-02-10 Tyco Healthcare Group Lp Surgical wound dressing incorporating connected hydrogel beads having an embedded electrode therein
EP2386289A1 (en) * 2010-04-29 2011-11-16 Ipsen Pharma S.A.S. Clay compositions
CN103269673B (zh) * 2010-12-23 2018-02-02 高露洁-棕榄公司 包含结构化剂的流体组合物
CN103974691A (zh) 2011-12-15 2014-08-06 高露洁-棕榄公司 水性口腔护理组合物
US20140178456A1 (en) * 2012-08-30 2014-06-26 Udaya Sankar Devanaboyina Methods and compositions for treating type 2 diabetes and related conditions
WO2014088534A1 (en) * 2012-12-03 2014-06-12 Colgate-Palmolive Company Manufacturing processes for gellan gum-based fluid gels
US11931227B2 (en) 2013-03-15 2024-03-19 Cook Medical Technologies Llc Bimodal treatment methods and compositions for gastrointestinal lesions with active bleeding
PL3137059T3 (pl) * 2014-04-29 2018-10-31 The Procter & Gamble Company Metoda wytwarzania płynnych zawiesin farmaceutycznych zawierających bizmut
RU2676261C2 (ru) * 2014-04-29 2018-12-27 Дзе Проктер Энд Гэмбл Компани Жидкие фармацевтические суспензии, содержащие висмут
WO2016011028A1 (en) 2014-07-14 2016-01-21 University Of Utah Research Foundation In situ solidifying complex coacervates and methods of making and using thereof
JP2017178881A (ja) * 2016-03-31 2017-10-05 小林製薬株式会社 経口組成物
JP6950312B2 (ja) * 2017-07-12 2021-10-13 ライオン株式会社 液体医薬組成物及び医薬品
JP2019064980A (ja) * 2017-10-03 2019-04-25 小林製薬株式会社 逆流性食道炎改善剤
WO2019147922A2 (en) 2018-01-26 2019-08-01 Fluidx Medical Technology, Llc Apparatus and method of using in situ solidifying complex coacervates for vascular occlusion

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5296241A (en) * 1991-04-03 1994-03-22 Brimberg Barnett J Therapeutic composition and method of using same for treatment of hangover
GB9114950D0 (en) * 1991-07-11 1991-08-28 Smithkline Beecham Plc Pharmaceutical formulation
WO1994020074A1 (en) * 1993-03-12 1994-09-15 The Procter & Gamble Company Adsorbate compositions

Also Published As

Publication number Publication date
EP1115378A1 (en) 2001-07-18
ID27728A (id) 2001-04-26
CN1313755A (zh) 2001-09-19
AU5685299A (en) 2000-03-14
BR9913227A (pt) 2001-05-22
CA2338688A1 (en) 2000-03-02
HUP0103216A2 (hu) 2002-01-28
CO5140071A1 (es) 2002-03-22
NO20010833D0 (no) 2001-02-19
JP2002523352A (ja) 2002-07-30
WO2000010527A1 (en) 2000-03-02
PE20000860A1 (es) 2000-09-11
US20010016577A1 (en) 2001-08-23
KR20010072463A (ko) 2001-07-31
TR200100629T2 (tr) 2001-07-23

Similar Documents

Publication Publication Date Title
NO20010833L (no) Orale mukoadhesive sammensetninger inneholdende gastrointestinale aktive bestanddeler
BE2015C026I2 (en) 2-phenyl-1-[-(2-aminoethoxy)-benzyl -indole in combination with estrogens
NO982414L (no) Ny kombinasjon
ATE286500T1 (de) 1,2,3,4-tetrahydroisochinolin-derivate
NO20052335L (no) Dispergerbare deferacirox-tabletter
ATE525061T1 (de) Feste selbst-haftende zusammensetzungen zur topischen behandlung von störungen der mundschleimhaut
HUP0300342A2 (hu) Carvedilol hidrofil molekuláris diszperziós oldatait tartalmazó készítmények, eljárás az előállításukra és alkalmazásuk
NO952863D0 (no) Fluoxetin-farmasöytiske sammensetninger
FI954944A (fi) Indolijohdannaisia 5-HT1-kaltaisina agonisteina käytettäväksi migreenin hoitoon
NO20010486L (no) Betennelseshemmende tannpleiemidler
CA2378428A1 (en) Use of cgrp antagonists and cgrp release inhibitors for combating menopausal hot flushes
IS4553A (is) Lyfjablöndur sem innihalda mónóamín oxídasa B blokkara
WO2000040232A3 (en) Bretylium compositions and kits, and their use in preventing and treating cardiovascular conditions
NO20005981L (no) Anvendelse av 2-hydroksy-4-trifluorbenzosyrederivater som inhibitorer av aktivering av den nukleære transkripsjonsfaktor NF- <kappa>B
NO975726D0 (no) N-Hydroksyurea-derivater som anti-inflammatoriske midler
HUP0100390A2 (hu) Eljárás baktericid hatás kifejtésére baktericid zsírsavszappan-frakciót tartalmazó készítmény alkalmazásával
ATE160938T1 (de) Feste orale pharmazeutische zubereitung mit gemfibrozil als aktiver inhaltsstoff und verfahren zur herstellung
DK0722325T3 (da) Præparat til behandling eller forebyggelse af herpes
NO20022971L (no) Butyndiol-derivater
US20120094882A1 (en) Denture Cleanser
ATE473962T1 (de) C2-disubstituierte indan-1-one und ihre derivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application